Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML

• Jesse M. Tettero,
• Yara Buisman,
• Lok Lam Ngai,
• Costa Bachas,
• Bjorn T. Gjertsen,
• Angèle Kelder,
• Arjan A. van de Loosdrecht,
• Markus G. Manz,
• Thomas Pabst,
• Willemijn Scholten,
• Gert J. Ossenkoppele,
• Jacqueline Cloos,
• David C. de Leeuw

Affiliations

Jesse M. Tettero

1 Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands

Yara Buisman

1 Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands

Lok Lam Ngai

1 Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands

Costa Bachas

1 Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands

Bjorn T. Gjertsen

3 Haukeland University Hospital, Bergen, Norway

Angèle Kelder

1 Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands

Arjan A. van de Loosdrecht

1 Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands

Markus G. Manz

4 Department of Medical Oncology and Hematology, University Hospital, Zurich, Switzerland

Thomas Pabst

5 Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland

Willemijn Scholten

1 Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands

Gert J. Ossenkoppele

1 Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands

Jacqueline Cloos

1 Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands

David C. de Leeuw

1 Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands